Vol 2007, No 82 (2007)

Table of Contents

Cartoons

Security jpg
Business Review Editor

Deal Trackers

Vyvanse (lisdexamfetamine dimesylate) Abstract pdf
Business Review Editor

Research & Development

Bristol-Myers Squibb and Adnexus Therapeutics in Collaboration for Cancer Biologics Abstract pdf
Business Review Editor
Avalon Enters into Collaborative R&D Deal Worth a Potential US$200 M Abstract pdf
Business Review Editor

Features

BioCryst: The Fall and Rise of Peramivir Abstract pdf
Business Review Editor
Cytyc - A Positive Outlook Abstract pdf
Business Review Editor
Valuation Methodologies in Biotech Abstract pdf
Business Review Editor
Therapy Focus: Attention Deficit Hyperactivity Disorder Abstract pdf
Business Review Editor

Licensing

Salix Expands Product Portfolio through Merck & Co. Licensing Deal Abstract pdf
Business Review Editor

General

Wyeth Alters R&D to Address the Emerging Challenges Facing Biotech Abstract
Business Review Editor
MediGene AG Abstract
Business Review Editor

Mergers & Acquisitions

Schering-Plough in US$14.4 B Acquisition of Organon BioSciences Abstract pdf
Business Review Editor
Smith & Nephew’s Acquisition of Plus Orthopedics Makes it Key Player in Reconstructive Surgery Market Abstract pdf
Business Review Editor

Business Commentaries

How Virtual Biotech has Changed the World Abstract html
Fintan Walton


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.